Serum Proteomics in Biomedical Research: A Systematic Review

被引:60
作者
Zhang, Ai-hua [1 ,2 ]
Sun, Hui [1 ,2 ]
Yan, Guang-li [1 ,2 ]
Han, Ying [1 ,2 ]
Wang, Xi-jun [1 ,2 ]
机构
[1] Natl TCM Key Lab Serum Pharmacochem, Key Lab Chinmed, Harbin 150040, Peoples R China
[2] Heilongjiang Univ Chinese Med, Harbin 150040, Peoples R China
关键词
Proteomics; Serum; Proteins; Biomarkers; Disease diagnosis; System biology; FLIGHT MASS-SPECTROMETRY; LASER-DESORPTION/IONIZATION-TIME; POLYACRYLAMIDE-GEL ELECTROPHORESIS; EPITHELIAL OVARIAN-CANCER; STAGE BREAST-CANCER; PROSTATE-CANCER; PARKINSONS-DISEASE; PANCREATIC-CANCER; LIVER-DISEASE; MYCOBACTERIUM-TUBERCULOSIS;
D O I
10.1007/s12010-013-0238-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Proteins that are important indicators of physiological or pathological states may contribute to the early diagnosis of disease, which may provide a basis for identifying the underlying mechanism of disease development. Serum, contains an abundance of proteins, offers an easy and inexpensive approach for disease detection and possesses a high potential to revolutionize the diagnostics. These differentially expressed proteins in serum have become an important role to monitoring the state for disease. Availability of emerging proteomic techniques gives optimism that serum can eventually be placed as a biomedium for clinical diagnostics. Advancements have benefited biomarker research to the point where serum is now recognized as an excellent diagnostic medium for the detection of disease. Comprehensive proteome of human serum fluid with high accuracy and availability has the potential to open new doors for disease biomarker discovery and for disease diagnostics, providing insights useful for future study. Thus, this review presents an overview of the value of serum as a credible diagnostic tool, and we aim to summarize the proteomic technologies currently used for global analysis of serum proteins and to elaborate on the application of serum proteomics to the discovery of disease biomarkers, and discuss some of the critical challenges and perspectives for this emerging field.
引用
收藏
页码:774 / 786
页数:13
相关论文
共 74 条
[1]   Structure of a mutant human purine nucleoside phosphorylase with the prodrug, 2-fluoro-2′-deoxyadenosine and the cytotoxic drug, 2-fluoroadenine [J].
Afshar, Sepideh ;
Sawaya, Michael R. ;
Morrison, Sherie L. .
PROTEIN SCIENCE, 2009, 18 (05) :1107-1114
[2]   Serum proteome profiling detects myelodysplastic syndromes and identifies CXC chemokine ligands 4 and 7 as markers for advanced disease [J].
Aivado, Manuel ;
Spentzos, Dimitrios ;
Germing, Ulrich ;
Alterovitz, Gil ;
Meng, Xiao-Ying ;
Grall, Franck ;
Giagounidis, Aristoteles A. N. ;
Klement, Giannoula ;
Steidl, Ulrich ;
Otu, Hasan H. ;
Czibere, Akos ;
Prall, Wolf C. ;
Iking-Konert, Christof ;
Shayne, Michelle ;
Ramoni, Marco F. ;
Gattermann, Norbert ;
Haas, Rainer ;
Mitsiades, Constantine S. ;
Fung, Eric T. ;
Libermann, Towia A. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (04) :1307-1312
[3]   Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry-based amino acid analysis [J].
Alterman, MA ;
Gogichayeva, NV ;
Kornilayev, BA .
ANALYTICAL BIOCHEMISTRY, 2004, 335 (02) :184-191
[4]   The crystal structure of the Mycobacterium tuberculosis Rv3019c-Rv3020c ESX complex reveals a domain-swapped heterotetramer [J].
Arbing, Mark A. ;
Kaufmann, Markus ;
Phan, Tung ;
Chan, Sum ;
Cascio, Duilio ;
Eisenberg, David .
PROTEIN SCIENCE, 2010, 19 (09) :1692-1703
[5]  
Besson D, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.009712-1, 10.1074/mcp.M111.009712]
[6]   Serum Proteomic Approach for the Identification of Serum Biomarkers Contributed by Oral Squamous Cell Carcinoma and Host Tissue Microenvironment [J].
Bijian, Krikor ;
Mlynarek, Alex M. ;
Balys, Richard L. ;
Jie, Su ;
Xu, Yingjie ;
Hier, Michael P. ;
Black, Martin J. ;
Di Falco, Marcos R. ;
LaBoissiere, Sylvie ;
Alaoui-Jamali, Moulay A. .
JOURNAL OF PROTEOME RESEARCH, 2009, 8 (05) :2173-2185
[7]   Serum proteome profiling of primary breast cancer indicates a specific biomarker profile [J].
Boehm, Daniel ;
Keller, Ksenia ;
Wehrwein, Nelli ;
Lebrecht, Antje ;
Schmidt, Marcus ;
Koelbl, Heinz ;
Grus, Franz-Hermann .
ONCOLOGY REPORTS, 2011, 26 (05) :1051-1056
[8]   Ovarian cancer in the proteomics era: diagnosis, prognosis, and therapeutics targets [J].
Boyce, EA ;
Kohn, EC .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2005, 15 :266-273
[9]   ACR Appropriateness Criteria© Ovarian Cancer Screening [J].
Brown, Douglas L. ;
Andreotti, Rochelle F. ;
Lee, Susanna I. ;
Allison, Sandra O. DeJesus ;
Bennett, Genevieve L. ;
Dubinsky, Theodore ;
Glanc, Phyllis ;
Horrow, Mindy M. ;
Lev-Toaff, Anna S. ;
Horowitz, Neil S. ;
Podrasky, Ann E. ;
Scoutt, Leslie M. ;
Zelop, Carolyn M. .
ULTRASOUND QUARTERLY, 2010, 26 (04) :219-223
[10]   Mycobacterium tuberculosis Lipolytic Enzymes as Potential Biomarkers for the Diagnosis of Active Tuberculosis [J].
Brust, Belinda ;
Lecoufle, Melanie ;
Tuaillon, Edouard ;
Dedieu, Luc ;
Canaan, Stephane ;
Valverde, Viviane ;
Kremer, Laurent .
PLOS ONE, 2011, 6 (09)